Medication info
Tenelpolamine Sustained-release Tablet 20/1000 mg

Tenelpolamine Sustained-release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›26mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Pink oval-shaped sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201320 · Approved 2022.04.04 · Insurance code 669908180

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes

View approved original text

This medication helps to control blood glucose levels in patients with type 2 diabetes by combining teneligliptin and metformin. It is suitable for patients following diet and exercise therapy, and is used to enhance the effectiveness of blood glucose management and improve diabetes symptoms.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for the treatment of diabetes and should not be administered to patients with poor kidney function. It should be avoided particularly in cases of severe renal impairment, heart failure, acute myocardial infarction, or sepsis. Before tests involving radiographic iodine contrast agents, this medication should be discontinued at least 48 hours beforehand, and reinitiated only after confirming normal kidney function. It is safest not to use this medication in pregnant women or those who may become pregnant. This medication can cause hypoglycemia, so caution is especially required when used in conjunction with insulin or sulfonylureas. Additionally, patients with acute pancreatitis or liver function impairment should also exercise caution when taking this medication. Should any serious symptoms such as severe abdominal pain, vomiting, shortness of breath, or weakness occur during treatment, consult a doctor immediately. Elderly patients may have reduced kidney function and should have regular kidney function tests, adjusting the dose if necessary. Alcohol consumption may increase the risk of lactic acidosis, so it's best to avoid drinking during treatment. Vitamin B12 levels may decrease, so regular blood tests should be conducted and supplementation provided if needed. Patients must be fully aware of the symptoms of hypoglycemia and how to respond, and should take immediate appropriate measures should symptoms arise. In cases where oral intake is difficult due to surgery, severe infection, or trauma, this medication should be temporarily suspended and resumed only once the patient’s condition has improved. This medication is not used in children due to lack of established safety and efficacy. In case of overdose, immediate medical attention should be sought, and dialysis may be required if kidney function is compromised. It is important to store this medication out of the reach of children and not transfer it to another container.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigoid
  • acute pancreatitis
  • dizziness
Show 104 more
  • abdominal bloating
  • abdominal discomfort
  • nausea
  • abdominal pain
  • distension
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcers
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • elevated serum potassium concentration
  • fatigue
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • epigastric pain
  • gastritis
  • upper respiratory tract infection
  • tremor
  • headaches
  • asthenia
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory tract infection
  • rhinitis
  • cold sweats
  • diabetic retinopathy
  • vision decline
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headaches
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • cerebral infarction
  • hepatic coma
  • lumbar spinal canal stenosis
  • spinal intervertebral disc protrusion
  • spinal intervertebral disc disorders
  • spinal ligament ossification
  • spinal foraminal stenosis
  • rotator cuff syndrome
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorders
  • gastrointestinal motility reduction
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • increased blood sugar
  • abnormal sputum
  • toxic hepatitis
  • chronic cholecystitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • pressure ulcer
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina pectoris
  • otalgia
  • vertigo
  • iron deficiency anemia
  • food allergy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that is well-ventilated, and ideally kept at room temperature between 1 and 30 degrees Celsius. This helps to maintain the medication's potency and prevent degradation.

Appearance and packaging

Appearance

Pink oval-shaped sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.